Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 May 1;26(9):2173–2178. doi: 10.1093/nar/26.9.2173

STAT 5 and NF-Y are involved in expression and growth hormone-mediated sexually dimorphic regulation of cytochrome P450 3A10/lithocholic acid 6beta-hydroxylase.

A Subramanian 1, J Wang 1, G Gil 1
PMCID: PMC147524  PMID: 9547277

Abstract

The level of expression of a number of sexually differentiated liver proteins is primarily determined by plasma growth hormone (GH). Adult males have a pulsatile profile of GH release, while females have a relatively steady-state pattern of GH release. An important subset of these sexually differentiated hepatic proteins is certain cytochrome P450s (P450s). CYP3A10/6beta-hydroxylase is a male-specific P450 that catalyzes 6beta-hydroxylation of lithocholic acid, and the pattern of GH secretion is directly responsible for male-specific expression of this gene. The DNA element involved in GH-mediated regulation of CYP3A10/6beta-hydroxylase promoter activity binds a member of the STAT (signal transducers and activators of transcription) family of proteins. In this study we functionally demonstrate that two members of the STAT family, STAT 5a and STAT 5b, mediate GH-dependent regulation of CYP3A10/6beta-hydroxylase promoter activity. Furthermore, a neighboring DNA element binds NF-Y, a transcription factor involved in maintaining high levels of transcription of many genes and known to functionally interact with other factors. In the CYP3A10/6beta-hydroxylase gene, NF-Y also modulates binding of STAT 5, thereby modulating GH-mediated activation of its transcription.

Full Text

The Full Text of this article is available as a PDF (120.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson S., Davis D. L., Dahlbäck H., Jörnvall H., Russell D. W. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem. 1989 May 15;264(14):8222–8229. [PubMed] [Google Scholar]
  2. Carter-Su C., Schwartz J., Smit L. S. Molecular mechanism of growth hormone action. Annu Rev Physiol. 1996;58:187–207. doi: 10.1146/annurev.ph.58.030196.001155. [DOI] [PubMed] [Google Scholar]
  3. Chang T. K., Teixeira J., Gil G., Waxman D. J. The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation. Biochem J. 1993 Apr 15;291(Pt 2):429–433. doi: 10.1042/bj2910429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
  5. Ericsson J., Jackson S. M., Lee B. C., Edwards P. A. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):945–950. doi: 10.1073/pnas.93.2.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Galsgaard E. D., Gouilleux F., Groner B., Serup P., Nielsen J. H., Billestrup N. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol Endocrinol. 1996 Jun;10(6):652–660. doi: 10.1210/mend.10.6.8776725. [DOI] [PubMed] [Google Scholar]
  7. Gebert C. A., Park S. H., Waxman D. J. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol. 1997 Apr;11(4):400–414. doi: 10.1210/mend.11.4.9904. [DOI] [PubMed] [Google Scholar]
  8. Gil G., Osborne T. F., Goldstein J. L., Brown M. S. Purification of a protein doublet that binds to six TGG-containing sequences in the promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1988 Dec 15;263(35):19009–19019. [PubMed] [Google Scholar]
  9. Gorski K., Carneiro M., Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell. 1986 Dec 5;47(5):767–776. doi: 10.1016/0092-8674(86)90519-2. [DOI] [PubMed] [Google Scholar]
  10. Gronowski A. M., Zhong Z., Wen Z., Thomas M. J., Darnell J. E., Jr, Rotwein P. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Mol Endocrinol. 1995 Feb;9(2):171–177. doi: 10.1210/mend.9.2.7776967. [DOI] [PubMed] [Google Scholar]
  11. Jackson D. A., Rowader K. E., Stevens K., Jiang C., Milos P., Zaret K. S. Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol. 1993 Apr;13(4):2401–2410. doi: 10.1128/mcb.13.4.2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jackson S. M., Ericsson J., Osborne T. F., Edwards P. A. NF-Y has a novel role in sterol-dependent transcription of two cholesterogenic genes. J Biol Chem. 1995 Sep 15;270(37):21445–21448. doi: 10.1074/jbc.270.37.21445. [DOI] [PubMed] [Google Scholar]
  13. Jump D. B., Badin M. V., Thelen A. The CCAAT box binding factor, NF-Y, is required for thyroid hormone regulation of rat liver S14 gene transcription. J Biol Chem. 1997 Oct 31;272(44):27778–27786. doi: 10.1074/jbc.272.44.27778. [DOI] [PubMed] [Google Scholar]
  14. Le Cam A., Pantescu V., Paquereau L., Legraverend C., Fauconnier G., Asins G. cis-Acting elements controlling transcription from rat serine protease inhibitor 2.1 gene promoter. Characterization of two growth hormone response sites and a dominant purine-rich element. J Biol Chem. 1994 Aug 26;269(34):21532–21539. [PubMed] [Google Scholar]
  15. Mantovani R., Li X. Y., Pessara U., Hooft van Huisjduijnen R., Benoist C., Mathis D. Dominant negative analogs of NF-YA. J Biol Chem. 1994 Aug 12;269(32):20340–20346. [PubMed] [Google Scholar]
  16. Mantovani R., Pessara U., Tronche F., Li X. Y., Knapp A. M., Pasquali J. L., Benoist C., Mathis D. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J. 1992 Sep;11(9):3315–3322. doi: 10.1002/j.1460-2075.1992.tb05410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mantovani R., Pessara U., Tronche F., Li X. Y., Knapp A. M., Pasquali J. L., Benoist C., Mathis D. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J. 1992 Sep;11(9):3315–3322. doi: 10.1002/j.1460-2075.1992.tb05410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miyal K., Mayr W. W., Richardson A. L. Acute cholestasis induced by lithocholic acid in the rat. A freeze-fracture replica and thin section study. Lab Invest. 1975 Apr;32(4):527–535. [PubMed] [Google Scholar]
  19. Mui A. L., Wakao H., O'Farrell A. M., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995 Mar 15;14(6):1166–1175. doi: 10.1002/j.1460-2075.1995.tb07100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ram P. A., Park S. H., Choi H. K., Waxman D. J. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem. 1996 Mar 8;271(10):5929–5940. doi: 10.1074/jbc.271.10.5929. [DOI] [PubMed] [Google Scholar]
  21. Ronchi A., Bellorini M., Mongelli N., Mantovani R. CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. Nucleic Acids Res. 1995 Nov 25;23(22):4565–4572. doi: 10.1093/nar/23.22.4565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Roy A. K., Chatterjee B. Sexual dimorphism in the liver. Annu Rev Physiol. 1983;45:37–50. doi: 10.1146/annurev.ph.45.030183.000345. [DOI] [PubMed] [Google Scholar]
  23. Sadowski H. B., Gilman M. Z. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature. 1993 Mar 4;362(6415):79–83. doi: 10.1038/362079a0. [DOI] [PubMed] [Google Scholar]
  24. Smit L. S., Vanderkuur J. A., Stimage A., Han Y., Luo G., Yu-Lee L. Y., Schwartz J., Carter-Su C. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Endocrinology. 1997 Aug;138(8):3426–3434. doi: 10.1210/endo.138.8.5332. [DOI] [PubMed] [Google Scholar]
  25. Smith J. R., Osborne T. F., Brown M. S., Goldstein J. L., Gil G. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Biol Chem. 1988 Dec 5;263(34):18480–18487. [PubMed] [Google Scholar]
  26. Steimle V., Otten L. A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993 Oct 8;75(1):135–146. [PubMed] [Google Scholar]
  27. Subramanian A., Teixeira J., Wang J., Gil G. A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6 beta-hydroxylase gene expression by growth hormone. Mol Cell Biol. 1995 Sep;15(9):4672–4682. doi: 10.1128/mcb.15.9.4672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Teixeira J., Gil G. Cloning, expression, and regulation of lithocholic acid 6 beta-hydroxylase. J Biol Chem. 1991 Nov 5;266(31):21030–21036. [PubMed] [Google Scholar]
  29. Thomas M. J., Gronowski A. M., Berry S. A., Bergad P. L., Rotwein P. Growth hormone rapidly activates rat serine protease inhibitor 2.1 gene transcription and induces a DNA-binding activity distinct from those of Stat1, -3, and -4. Mol Cell Biol. 1995 Jan;15(1):12–18. doi: 10.1128/mcb.15.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A., Waxman D. J., Davey H. W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7239–7244. doi: 10.1073/pnas.94.14.7239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Waxman D. J., Ram P. A., Park S. H., Choi H. K. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem. 1995 Jun 2;270(22):13262–13270. doi: 10.1074/jbc.270.22.13262. [DOI] [PubMed] [Google Scholar]
  32. Wood T. J., Sliva D., Lobie P. E., Pircher T. J., Gouilleux F., Wakao H., Gustafsson J. A., Groner B., Norstedt G., Haldosén L. A. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J Biol Chem. 1995 Apr 21;270(16):9448–9453. doi: 10.1074/jbc.270.16.9448. [DOI] [PubMed] [Google Scholar]
  33. Xu B. C., Wang X., Darus C. J., Kopchick J. J. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem. 1996 Aug 16;271(33):19768–19773. [PubMed] [Google Scholar]
  34. Yokoyama C., Wang X., Briggs M. R., Admon A., Wu J., Hua X., Goldstein J. L., Brown M. S. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993 Oct 8;75(1):187–197. [PubMed] [Google Scholar]
  35. Zaphiropoulos P. G., Mode A., Norstedt G., Gustafsson J. A. Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol Sci. 1989 Apr;10(4):149–153. doi: 10.1016/0165-6147(89)90167-3. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES